Synapse - Andrea Knezevic

Search Within

Andrea Knezevic

Results (109)

Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer

Journal Article

Gollub, M. J.; Blazic, I.; Felder, S.; Knezevic, A.; Gonen, M.; Garcia-Aguilar, J.; Paty, P. P.; Smith, J. J.
European Radiology (2019)

Fulltext@MSK | Save

CT colonography in preoperative staging of colon cancer: Evaluation of FOxTROT inclusion criteria for neoadjuvant therapy

Journal Article

Horvat, N.; Raj, A.; Liu, S.; Matkowskyj, K. A.; Knezevic, A.; Capanu, M.; Shia, J.; Pickhardt, P. J.; Gollub, M. J.
American Journal of Roentgenology (2019)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)

Meeting Abstract

Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial

Meeting Abstract

Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma

Meeting Abstract

Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
Blood (2018)

Fulltext@MSK | Save

Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma

Meeting Abstract

Bachier Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H. J.; Giralt, S.
Blood (2018)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save